NO971768L - Hemoglobinreseptorer fra Neisseriae - Google Patents
Hemoglobinreseptorer fra NeisseriaeInfo
- Publication number
- NO971768L NO971768L NO971768A NO971768A NO971768L NO 971768 L NO971768 L NO 971768L NO 971768 A NO971768 A NO 971768A NO 971768 A NO971768 A NO 971768A NO 971768 L NO971768 L NO 971768L
- Authority
- NO
- Norway
- Prior art keywords
- proteins
- nucleic acids
- antibodies
- hemoglobin receptor
- apples
- Prior art date
Links
- 108010054147 Hemoglobins Proteins 0.000 title abstract 3
- 102000001554 Hemoglobins Human genes 0.000 title abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 6
- 102000039446 nucleic acids Human genes 0.000 abstract 4
- 108020004707 nucleic acids Proteins 0.000 abstract 4
- 150000007523 nucleic acids Chemical class 0.000 abstract 4
- 102000004169 proteins and genes Human genes 0.000 abstract 4
- 102000005962 receptors Human genes 0.000 abstract 3
- 108020003175 receptors Proteins 0.000 abstract 3
- 101710183906 Bacterial hemoglobin Proteins 0.000 abstract 2
- 241000220225 Malus Species 0.000 abstract 2
- 235000021016 apples Nutrition 0.000 abstract 2
- 230000001225 therapeutic effect Effects 0.000 abstract 2
- 229960005486 vaccine Drugs 0.000 abstract 2
- 241000588653 Neisseria Species 0.000 abstract 1
- 241000588652 Neisseria gonorrhoeae Species 0.000 abstract 1
- 108091005804 Peptidases Proteins 0.000 abstract 1
- 102000035195 Peptidases Human genes 0.000 abstract 1
- 239000004365 Protease Substances 0.000 abstract 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 abstract 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 abstract 1
- 244000052616 bacterial pathogen Species 0.000 abstract 1
- 238000012512 characterization method Methods 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 238000002649 immunization Methods 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000002955 isolation Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000003259 recombinant expression Methods 0.000 abstract 1
- 241000894007 species Species 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/825—Bacteria
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Foreliggende oppfinnelse angår nye bakterielle hemogloblnreseptorprotelner og gener som koder for slike proteiner. Oppfinnelsen er rettet mot isolering, karakterisering, diagnostisk og terapeutisk anvendelse av bakterielle hemogloblnreseptorprotelner, nuklein- syrer kodende for slike proteiner, rekoinbinante ekspresjonskonstrukter omfattende slike nukleinsyrer og celler transformert til dette, og antistoffer og epltoper av slike hemoglobinreseptorproteiner. Oppfinnelsen angår spesielt hemogloblnreseptorprotelner og gener kodende for slike proteiner fra Nelsseria- arter, spesielt K. meningitldls og serotyper derav, og N. gonorrhoeae. Fremgangsmåter for diagnostisering og terapeutisk anvendelse av proteiner, epltoper, antistoffer og nukleinsyrer ifølge foreliggende oppfinnelse er også tilveiebragt, innbefattet anven- delse av proteiner, epltoper, antistoffer og nuklein- syrer ifølge oppfinnelsen for produksjon av vaksiner som er effektive i å tilveiebringe immunisering av et itienneske mot infeksjon av patogeniske bakterier av Neisseria-arter.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/326,670 US5698438A (en) | 1994-10-18 | 1994-10-18 | Bacterial hemoglobin receptor gene |
US08/537,361 US6121037A (en) | 1994-10-18 | 1995-10-02 | Bacterial hemoglobin receptor genes |
PCT/US1995/013623 WO1996012020A2 (en) | 1994-10-18 | 1995-10-17 | Hemoglobin receptors from neisseriae |
Publications (2)
Publication Number | Publication Date |
---|---|
NO971768D0 NO971768D0 (no) | 1997-04-17 |
NO971768L true NO971768L (no) | 1997-06-03 |
Family
ID=26985503
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO971768A NO971768L (no) | 1994-10-18 | 1997-04-17 | Hemoglobinreseptorer fra Neisseriae |
Country Status (8)
Country | Link |
---|---|
US (2) | US6121037A (no) |
JP (1) | JPH10508469A (no) |
AU (1) | AU705509B2 (no) |
CA (1) | CA2203116A1 (no) |
FI (1) | FI971634A (no) |
HU (1) | HUT77048A (no) |
NO (1) | NO971768L (no) |
WO (1) | WO1996012020A2 (no) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0749321B1 (en) * | 1994-02-09 | 2007-01-24 | Epitopix LLC | Active immunization using a siderophore receptor protein |
US5830479A (en) * | 1994-02-09 | 1998-11-03 | Willmar Poultry Company, Inc. | Active immunization using a siderophore receptor protein |
US6121037A (en) | 1994-10-18 | 2000-09-19 | Stojiljkovic; Igor | Bacterial hemoglobin receptor genes |
FR2751000B1 (fr) | 1996-07-12 | 1998-10-30 | Inst Nat Sante Rech Med | Adn specifiques des bacteries de l'espece neisseria meningitidis, leurs procedes d'obtention et leurs applications biologiques |
US6914131B1 (en) | 1998-10-09 | 2005-07-05 | Chiron S.R.L. | Neisserial antigens |
CA2308606A1 (en) * | 1997-11-06 | 1999-05-20 | Chiron S.P.A. | Neisserial antigens |
GB9808866D0 (en) * | 1998-04-24 | 1998-06-24 | Smithkline Beecham Biolog | Novel compounds |
GB9810276D0 (en) * | 1998-05-13 | 1998-07-15 | Smithkline Beecham Biolog | Novel compounds |
FR2785293B1 (fr) * | 1998-10-30 | 2002-07-05 | Pasteur Merieux Serums Vacc | Acides nucleiques et polypeptides specifiques des souches pathogenes du genre neisseria |
EP1144643A1 (en) * | 1999-01-15 | 2001-10-17 | SMITHKLINE BEECHAM BIOLOGICALS s.a. | Neisseria meningitidis antigen |
DK1163343T3 (da) | 1999-03-12 | 2010-04-19 | Glaxosmithkline Biolog Sa | Neisseria meningitidis antigene polypeptider, tilsvarende polynukleotider og beskyttende antistoffer |
GB9911683D0 (en) * | 1999-05-19 | 1999-07-21 | Chiron Spa | Antigenic peptides |
AU784203B2 (en) | 1999-10-29 | 2006-02-23 | Glaxosmithkline Biologicals S.A. | Neisserial antigenic peptides |
GB0011108D0 (en) * | 2000-05-08 | 2000-06-28 | Microscience Ltd | Virulence gene and protein and their use |
CA2708949C (en) * | 2001-01-03 | 2016-03-08 | Epitopix Llc. | Immunizing compositions and methods of use |
ES2395022T3 (es) | 2003-09-19 | 2013-02-07 | Epitopix, Llc | Polipéptidos de Campylobacter y sus métodos de uso |
WO2010070453A2 (en) * | 2008-12-17 | 2010-06-24 | Novartis Ag | Meningococcal vaccines including hemoglobin receptor |
US10166280B2 (en) | 2016-06-08 | 2019-01-01 | Epitopix, Llc | Polypeptides and immunizing compositions containing Bacillus polypeptides and methods of use |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4683195A (en) * | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US5223409A (en) * | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
US5304487A (en) | 1992-05-01 | 1994-04-19 | Trustees Of The University Of Pennsylvania | Fluid handling in mesoscale analytical devices |
US6121037A (en) | 1994-10-18 | 2000-09-19 | Stojiljkovic; Igor | Bacterial hemoglobin receptor genes |
-
1995
- 1995-10-02 US US08/537,361 patent/US6121037A/en not_active Expired - Fee Related
- 1995-10-17 HU HU9701963A patent/HUT77048A/hu unknown
- 1995-10-17 AU AU40073/95A patent/AU705509B2/en not_active Ceased
- 1995-10-17 JP JP8513482A patent/JPH10508469A/ja active Pending
- 1995-10-17 CA CA002203116A patent/CA2203116A1/en not_active Abandoned
- 1995-10-17 WO PCT/US1995/013623 patent/WO1996012020A2/en not_active Application Discontinuation
-
1997
- 1997-04-17 NO NO971768A patent/NO971768L/no not_active Application Discontinuation
- 1997-04-17 FI FI971634A patent/FI971634A/fi unknown
-
2000
- 2000-09-19 US US09/665,358 patent/US7026157B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU705509B2 (en) | 1999-05-27 |
FI971634A0 (fi) | 1997-04-17 |
US6121037A (en) | 2000-09-19 |
JPH10508469A (ja) | 1998-08-25 |
US7026157B1 (en) | 2006-04-11 |
WO1996012020A2 (en) | 1996-04-25 |
FI971634A (fi) | 1997-06-16 |
AU4007395A (en) | 1996-05-06 |
NO971768D0 (no) | 1997-04-17 |
CA2203116A1 (en) | 1996-04-25 |
WO1996012020A3 (en) | 1996-05-23 |
HUT77048A (hu) | 1998-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO971768L (no) | Hemoglobinreseptorer fra Neisseriae | |
Hayman et al. | Mapping the minimal murine T cell and B cell epitopes within a peptide vaccine candidate from the conserved region of the M protein of group A streptococcus. | |
CN113365656A (zh) | 用于非洲猪瘟病毒的免疫原性组合物 | |
EA015833B1 (ru) | Иммуногенная композиция | |
CN101955545B (zh) | 一种多靶点重组基因及其蛋白在防治幽门螺旋杆菌感染中的应用 | |
CN101631858A (zh) | 用于预防和治疗脑膜炎球菌疾病的新颖免疫原性组合物 | |
CN1272062A (zh) | 含有b组脑膜炎球菌膜孔蛋白和流感嗜血菌多糖的免疫偶联物 | |
CN102256620A (zh) | 用于治疗阿尔茨海默氏病的免疫治疗组合物 | |
CN105142653A (zh) | 增强对肠病原体免疫应答的组合物和方法 | |
Khiav et al. | Vaccination against pathogenic clostridia in animals: a review | |
CN101848997B (zh) | 用于Myo-2肽多聚体和肌生成抑制素的融合蛋白表面表达载体以及由其转化的微生物 | |
Golshani et al. | Evaluation of Poly (I: C) and combination of CpG ODN plus Montanide ISA adjuvants to enhance the efficacy of outer membrane vesicles as an acellular vaccine against Brucella melitensis infection in mice | |
Fatehi et al. | Oral vaccination with novel Lactococcus lactis mucosal live vector-secreting Brucella lumazine synthase (BLS) protein induces humoral and cellular immune protection against Brucella abortus | |
KR100366482B1 (ko) | 백신으로서 정제된 분류가능하지 않은 헤모필루스 인프루엔자 p5단백질, 및 그의 정제방법 | |
BG98070A (bg) | Получаване и използване на убити с формалин организми от вида е.соli, експресиращи антиген на колоний- образуващия фактор, за ваксиниране срещу чревни инфекции/диарии, причинени от ентеротоксични бактерии на e.coli у хората | |
CN109293753A (zh) | 一种肠毒素型大肠杆菌四价纤毛蛋白免疫原及其制备方法 | |
KR20130125771A (ko) | 다가 키메라 ospc 백시노겐 및 진단 항원 | |
Heesemann et al. | Monoclonal antibodies directed against plasmid-encoded released proteins of enteropathogenic Yersinia | |
Akkoyunlu et al. | The acylated form of protein D of Haemophilus influenzae is more immunogenic than the nonacylated form and elicits an adjuvant effect when it is used as a carrier conjugated to polyribosyl ribitol phosphate | |
CN104072590B (zh) | 一种脑膜炎球菌抗原组合及其应用 | |
Georgousakis et al. | Moving forward: a mucosal vaccine against group A streptococcus | |
CN107970444A (zh) | 复合佐剂及含有该复合佐剂的疫苗 | |
CN115243715A (zh) | 保护以对抗血清型9、序列型16的猪链球菌的疫苗 | |
Robinson et al. | Adult worm homogenate of the nematode parasite Heligmosomoides polygyrus induces proliferation of naive T lymphocytes without MHC restriction | |
EP0694560A2 (en) | Production of antigens of Pasteurella |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |